Imlygic

NDC 55513-078 · Amgen Inc

Generic nametalimogene laherparepvec

Dosage formINJECTION, SUSPENSION

RouteINTRALESIONAL

Active ingredient(s)TALIMOGENE LAHERPAREPVEC

Strength1000000 [PFU]/mL

Marketing categoryBLA

Packages

55513-078-01 — 1 VIAL in 1 CARTON (55513-078-01) / 1 mL in 1 VIAL

J9325 — Injection, talimogene laherparepvec, per 1 million plaque forming units Medicare Part B payment limit (ASP + 6%): $77.34

FDA lists these products with the same active ingredient.

55513-079 — talimogene laherparepvec

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.